LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
Investec Lifts Kingfisher Price Target To 320p From 300p, Keeps Sell
----------
SOCGEN CUTS COMPASS GROUP PRICE TARGET TO 930 (1,010) PENCE - 'SELL'
----------
HSBC RAISES EXPERIAN TO 'BUY' ('HOLD') - TARGET 1290 (1150) PENCE
----------
Deutsche Bank Cuts Experian Price Target To 1,250p From 1,300p, Keeps Buy
----------
EXANE BNP CUTS MORRISON PRICE TARGET TO 150 (170) PENCE - 'UNDERPERFORM'
----------
KEPLER CHEUVREUX CUTS TESCO PRICE TARGET TO 176 (215) PENCE - 'HOLD'
----------
EXANE BNP CUTS SHELL PRICE TARGET TO 27.00 (31.60) PENCE - 'OUTPERFORM'
----------
Liberum Cuts Royal Dutch Shell 'B' Price Target To 1,850p From 2,120p, Keeps Hold
----------
EXANE BNP CUTS BP PRICE TARGET TO 330 (388) PENCE - 'NEUTRAL'
----------
Liberum Upgrades BP To Buy From Hold, Cuts Price Target To 405p From 435p
----------
Liberum Upgrades BG Group To Buy From Hold, Lifts Price Target To 1,165p From 886p
----------
UBS INITIATES LEGAL & GENERAL WITH 'SELL' - TARGET 207 PENCE
----------
CITIGROUP RAISES HARGREAVES LANSDOWN PRICE TARGET TO 1,000 (975) PENCE - 'SELL'
----------
GOLDMAN CUTS VODAFONE PRICE TARGET TO 245 (250) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BHP BILLITON PRICE TARGET TO 1000 (1050) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
BARCLAYS INITIATES SHAWBROOK WITH 'OVERWEIGHT' - TARGET 410 PENCE
----------
EXANE BNP CUTS TULLOW OIL PRICE TARGET TO 300 (457) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS PREMIER OIL PRICE TARGET TO 98 (184) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS OPHIR ENERGY PRICE TARGET TO 105 (127) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS CAIRN ENERGY PRICE TARGET TO 181 (217) PENCE - 'OUTPERFORM'
----------
BARCLAYS RAISES REDROW PRICE TARGET TO 568 (560) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS CLOSE BROTHERS TO EQUAL WEIGHT (OVERW) - TARGET 1500 (1650) PENCE
----------
BARCLAYS INITIATES ALDERMORE WITH 'EQUAL WEIGHT' - TARGET 310 PENCE
----------
UBS CUTS CARILLION PRICE TARGET TO 230 (235) PENCE - 'SELL'
----------
MAIN MARKET AND AIM
----------
NUMIS CUTS TLA WORLDWIDE TO 'ADD' ('BUY') - TARGET 67 (62) PENCE
----------
NUMIS CUTS ACCESSO TECHNOLOGY TO 'ADD' ('BUY') - TARGET 985 (910) PENCE
----------
N+1Singer Initiates Midatech Pharma With Buy, Price Target At 385p
----------
LIBERUM RAISES MANX TELECOM PRICE TARGET TO 214 (200) PENCE - 'BUY'
----------
EXANE BNP CUTS SOCO INTL TO 'NEUTRAL' ('OUTPERFORM') - TARGET 147 (158) PENCE
----------
EXANE BNP CUTS ROCKHOPPER EXPLORATION PRICE TARGET TO 59 (73) PENCE - 'NEUTRAL'
----------
WH Ireland Ups Eden Research Price Target To 24p From 17p, Keeps Speculative Buy
----------
JPMORGAN RAISES CHEMRING GROUP PRICE TARGET TO 215 (200) PENCE - 'NEUTRAL'
----------
Numis Lifts Wilmington Price Target To 360p From 345p, Reiterates Buy
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
IN BRIEF: Midatech Pharma delisting and name change approved
Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Says resolutions put forward at general meeting, including name change, share consolidation and cancellation of AIM listing, approved. Under the consolidation, every 20 shares will be consolidated into one new ordinary share. Adds that ratio of American depositary shares will change to one ADS per five shares, from one ADS per 25 shares previously. Name change to Biodexa Pharmaceuticals PLC, effective on Monday, also approved. Listing of shares on AIM is expected to be cancelled a month from now. Its sole listing will be on Nasdaq.
Read more